GO
Loading...

Lightning Round: Merck, Cummins, Visa and More

Deckers Outdoor : “I think Deckers can add 10 more points before year end,” Cramer said.

Merck : “Merck doesn’t have it,” Cramer said. “It just doesn’t have want I want.” Abbott Labs is a better pick.

Cummins : Cramer is bullish on CMI.

Eli Lilly : LLY works as a dividend play, Cramer said. But investors shouldn’t expect any growth out of the company until it releases a blockbuster drug.

Visa : Cramer said he likes Visa, but American Express even more.

optionsXpress : OXPS is a buy, Cramer said.

BlackRock : “I think business is great there,” Cramer said. BLK is a buy.

When this story published, Cramer’s charitable trust owned Abbot Labs, American Express and Cummins.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book